Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Aquestive Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −2 vs. Q4 2022
- Shares held
- 14.9M
- +11.8K (+0.1%) vs. Q4 2022
- Total value
- $17.0M
- +$3.57M (+26.5%) vs. Q4 2022
- New holders
- 8
- 7 more added
- Sold out
- 10
- 6 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AQST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $299.5M |
| Q1 2026 | 180 | $298.6M |
| Q4 2025 | 179 | $467.0M |
| Q3 2025 | 152 | $369.3M |
| Q2 2025 | 117 | $157.6M |
| Q1 2025 | 121 | $127.8M |
| Q4 2024 | 114 | $154.4M |
| Q3 2024 | 117 | $232.4M |
| Q2 2024 | 98 | $110.7M |
| Q1 2024 | 97 | $176.8M |
| Q4 2023 | 57 | $48.1M |
| Q3 2023 | 48 | $21.5M |
| Q2 2023 | 54 | $31.5M |
| Q1 2023 | 35 | $17.0M |
| Q4 2022 | 37 | $13.5M |
| Q3 2022 | 46 | $18.6M |
| Q2 2022 | 46 | $10.7M |
| Q1 2022 | 51 | $40.6M |
| Q4 2021 | 52 | $62.9M |
| Q3 2021 | 46 | $64.4M |
| Q2 2021 | 60 | $62.0M |
| Q1 2021 | 64 | $86.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Aquestive Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 185 | $0 | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 130 | $148 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 267 | $304 | 0.00% | −23,994−98.9% | Reduced |
| TCI Wealth Advisors, Inc. | 500 | $570 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,176 | $1.00K | 0.00% | +1,176 | New |
| Richard W. Paul & Associates, LLC | 1,423 | $1.62K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,000 | $2.28K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,744 | $4.27K | 0.00% | +3,744 | New |
| Morgan Stanley | 4,670 | $5.32K | 0.00% | −1,002−17.7% | Reduced |
| Tower Research Capital LLC (TRC) | 9,282 | $11.0K | 0.00% | +4,287+85.8% | Added |
| Wells Fargo & Company | 11,381 | $13.0K | 0.00% | +40.0% | Added |
| D.B. Root & Company, LLC | 12,500 | $14.3K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 12,884 | $15.0K | 0.00% | +12,884 | New |
| Bank of New York Mellon Corp | 14,853 | $16.9K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 15,542 | $17.7K | 0.00% | +15,542 | New |
| Bank of Montreal | 19,230 | $22.1K | 0.00% | −1,500−7.2% | Reduced |
| Two Sigma Advisers, LP | 23,100 | $26.3K | 0.00% | −9,300−28.7% | Reduced |
| Jane Street Group, LLC | 23,430 | $26.7K | 0.00% | +23,430 | New |
| Financial Advocates Investment Management | 25,000 | $28.5K | 0.00% | −7,000−21.9% | Reduced |
| HBK Sorce Advisory LLC | 42,348 | $48.3K | 0.00% | +42,348 | New |
| Northern Trust Corp | 59,828 | $68.2K | 0.00% | −2,262−3.6% | Reduced |
| Kestra Advisory Services, LLC | 86,350 | $98.4K | 0.00% | +86,350 | New |
| State Street Corp | 96,037 | $109.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 116,272 | $132.6K | 0.00% | +116,272 | New |
| HighTower Advisors, LLC | 130,305 | $148.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 142,956 | $163.0K | 0.00% | 00.0% | Unchanged |
| Latash Investments, LLC | 243,134 | $277.2K | 0.25% | 00.0% | Unchanged |
| Millennium Management LLC | 302,848 | $345.0K | 0.00% | +256,568+554.4% | Added |
| BlackRock Inc. | 359,658 | $410.0K | 0.00% | +1,943+0.5% | Added |
| Geode Capital Management, LLC | 387,575 | $441.8K | 0.00% | 00.0% | Unchanged |
| Bracebridge Capital, LLC | 428,571 | $488.6K | 0.28% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 518,800 | $591.0K | 0.00% | +56,063+12.1% | Added |
| Vahanian & Associates Financial Planning Inc. | 718,908 | $819.6K | 2.27% | +40,650+6.0% | Added |
| Vanguard Group Inc | 1,310,586 | $1.49M | 0.00% | +65,854+5.3% | Added |
| Bratton Capital Management, L.P. | 9,810,958 | $11.2M | 100.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −506,600−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −89,900−100.0% | Sold out |
| Beacon Pointe Advisors, LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,910−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −3,166−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Coppell Advisory Solutions Corp. | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −6,500−100.0% | Sold out |